Tower Research Capital LLC (TRC) - INHIBIKASE THERAPEUTICS INC ownership

INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 27 filers reported holding INHIBIKASE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of INHIBIKASE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$9
+80.0%
13,333
+23.3%
0.00%
Q4 2022$5
-99.9%
10,814
+75.4%
0.00%
Q3 2022$6,000
-50.0%
6,166
-61.5%
0.00%
Q2 2022$12,000
+500.0%
16,022
+903.3%
0.00%
Q1 2022$2,000
-80.0%
1,597
-75.0%
0.00%
Q4 2021$10,0000.0%6,400
+18.4%
0.00%
Q3 2021$10,000
+233.3%
5,406
+895.6%
0.00%
Q1 2021$3,0005430.00%
Other shareholders
INHIBIKASE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 937,500$696,0000.97%
HAMILTON LANE ADVISORS LLC 165,635$123,0000.05%
Redmond Asset Management, LLC 122,682$91,0000.03%
Retirement Planning Co of New England, Inc. 64,606$47,0000.03%
Antara Capital LP 403,000$299,0000.01%
ZEKE CAPITAL ADVISORS, LLC 93,800$70,0000.01%
Koshinski Asset Management, Inc. 65,377$49,0000.01%
K.J. Harrison & Partners Inc 18,300$14,0000.00%
Warberg Asset Management LLC 14,493$11,0000.00%
Shay Capital LLC 10,708$8,0000.00%
View complete list of INHIBIKASE THERAPEUTICS INC shareholders